Skip to Main Content
Skip Nav Destination


Exenatide

Basics

Name

Exenatide

Special Alerts

Glucagon-Like Peptide-1 Receptor Agonists Safety UpdateJanuary 2024

The FDA has been evaluating reports of suicidal thoughts or actions in patients treated wi...

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal